Home Medical
Centers as Suppliers Risks
Are there risks?
While donating excised tissue to repositories has no medical
risks to donors, there are other possible harms to consider.
Donors can be harmed by breaches of privacy
of their medical information. Since human tissue contains genetic
information, it can be a storehouse of information about individual
tissue donors. Moreover, since the tissue is being banked, presumably
it will yield more information about genetic probabilities for
disease in the future when knowledge of genetics expands. In
addition, some tissue is linked with associated clinical information
including sensitive personal and family history information (e.g.,
alcoholism, mental illness, reproductive choices, etc.).
Inappropriate release of medical information can harm individuals.
Donors can also be harmed if the process of tissue collection compromises
patient care.
Medical centers may be concerned that tissue
collection itself and/or for a commercial company may erode public
trust in their institutionby selling
tissue or
commercializing body parts or result in other negative perceptions.
Commercial repositories tend to license access to their tissue
inventories (and related services). Critics may consider the distinction
between selling tissue and licensing access to tissue a distinction
without a difference. How medical centers use any funds provided
by collaborations may also negatively affect the public perceptions
of the medical center. In addition, medical centers must collect
tissue in compliance with federal and state regulations for human
subject research, the federal Privacy Rule and state genetic privacy
and other laws. Medical centers could suffer fines or other actions
from non-compliance. In addition, there are liability issues that
might arise affecting stewardship of donor tissue/information
in collaborations with repositories.
Research can be hindered if tissue collection
is conducted in a manner that erodes public trust in research and
diminishes people’s
willingness to be tissue donors or subjects
in clinical trials. |